Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03728257 · ClinicalTrials.gov registry record · NA

Lung Transplant G0 (LTGO): Improving Self-Management of Exercise After Lung Transplantation

A NA study of Exercise and Lung Transplantation, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
88
Enrollment target
1
Study location

NCT03728257: Completed NA study of Exercise and Lung Transplantation, sponsored by University of Pittsburgh.

NCT03728257 is a NA study of Exercise and Lung Transplantation that has completed, run by University of Pittsburgh. The registered enrollment target is 88 participants, below the 8,909-participant average among 57 other Exercise trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03728257, a NA study of Exercise and Lung Transplantation, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
88 participants
Enrollment target
1
Study location

Study Summary

Estimated costs, from thirty days prior to lung transplant up through six months post surgery, exceed 1 million dollars per patient and routine medical costs average approximately fifty thousand dollars per year thereafter. Prior to transplant, lung transplant recipients self restrict activity due to severe respiratory limitations, resulting in reduced muscle mass and qualitative changes in large skeletal muscles. After transplant, despite improved lung function, studies consistently report that lung recipients fail to reach predicted physical function and physical activity. Nearly seventy percent are at risk of developing hypertension within the first five years due to side effects of immunosuppression and an inactive lifestyle worsens this risk. Consequently, full benefits of transplant may not be achieved. Few studies have tested ways to engage lung recipients in self management of exercise and adopt an active lifestyle. Lung Transplant Go LTGO is a behavioral exercise intervention that provides individualized exercise training integrated with behavioral coaching delivered in the recipient's home. Exercise training will focus on assisting lung recipients to learn and practice exercises to reverse muscle conditioning. Behavioral coaching will assist them to develop the skills to self manage physical activity in daily life and maintain this as a sustained habit using strategies that include incremental goal setting, self-monitoring, feedback and problem solving.

Primary Outcome

Walking was measured as the change in average steps per day calculated by FitBit worn for periods at baseline and 3 months. Minimum = 0, no upper limit. Higher scores mean a better outcome. Change = (3 month score minus baseline score).

Interventions

  • BEHAVIORAL Enhanced Usual Care
  • BEHAVIORAL LTGO-Home Based Exercise

Study Locations (1)

Pennsylvania

  • University of Pittsburgh, School of Nursing - Pittsburgh

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2019-04-01
Est. Completion 2023-09-30
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT03728257 record still lists

NCT03728257 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 8,909-participant average among 57 other Exercise trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Exercise appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT03728257 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03728257 about?

NCT03728257 is a clinical study titled "Lung Transplant G0 (LTGO): Improving Self-Management of Exercise After Lung Transplantation". Estimated costs, from thirty days prior to lung transplant up through six months post surgery, exceed 1 million dollars per patient and routine medical costs average approximately fifty thousand dollars per year thereafter. Prior to transplant, lung transplant recipients self restrict activity due t...

What is the current status of trial NCT03728257?

This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2019-04-01. Estimated completion is 2023-09-30.

What conditions does trial NCT03728257 study?

This clinical trial studies the following conditions: Exercise, Lung Transplantation.

What interventions are being tested in trial NCT03728257?

The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), LTGO-Home Based Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT03728257?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03728257 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Exercise

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03728257's enrollment target sits among peer trials

88 23rd of 57 higher than 35 of 57 other Exercise trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Exercise trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03843463 · 88 participants · Phase 2

    Escitalopram and Language Intervention for Subacute Aphasia

  • NCT04066348 · 88 participants · Phase 2

    TNF-α Treatment of Blast-Induced Tinnitus

  • NCT04331704 · 88 participants · Phase 4

    ANCHORS Alcohol & Sexual Health Study: UH3 Project

  • NCT04536103 · 88 participants

    Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03728257, the US trial registry maintained by the National Library of Medicine. NCT03728257 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.